<DOC>
	<DOCNO>NCT01766011</DOCNO>
	<brief_summary>The purpose study ass overall growth preterm infant feed reformulated preterm infant formula hospitalization . All study product meet level nutrient infant population specify Infant Formula Act subsequent amendment .</brief_summary>
	<brief_title>Evaluation Standard Preterm Infant Formula Fed Preterm Infants Hospital</brief_title>
	<detailed_description />
	<criteria>Subjects eligible study participation satisfy follow criterion : Birth weight 1000g 1800g Less equal 34 week 0 day gestational age birth Appropriate gestational age ( AGA ) Singleton twin birth Infant 21 day age less Infants follow condition prior and/or time study product initiation eligible entry study : Expected transfer another facility within 14 day Serious congenital abnormality may affect growth development Intubated ventilation time study product initiation Grade III IV periventricular/intraventricular hemorrhage ( PVH/IVH ) Maternal incapacity , maternal drug alcohol abuse pregnancy current abuse , maternal treatment consistent human immunodeficiency virus therapy Infant history major surgery Asphyxia define progressive hypoxemia hypercapnia significant metabolic acidemia Confirmed necrotizing enterocolitis confirm sepsis Current use plan use probiotic Participation another study approve</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Days</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>